1. Home
  2. IMRX vs QSI Comparison

IMRX vs QSI Comparison

Compare IMRX & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRX
  • QSI
  • Stock Information
  • Founded
  • IMRX 2008
  • QSI 2013
  • Country
  • IMRX United States
  • QSI United States
  • Employees
  • IMRX N/A
  • QSI N/A
  • Industry
  • IMRX Biotechnology: Pharmaceutical Preparations
  • QSI Biotechnology: Pharmaceutical Preparations
  • Sector
  • IMRX Health Care
  • QSI Health Care
  • Exchange
  • IMRX Nasdaq
  • QSI Nasdaq
  • Market Cap
  • IMRX 232.9M
  • QSI 226.8M
  • IPO Year
  • IMRX 2021
  • QSI N/A
  • Fundamental
  • Price
  • IMRX $6.49
  • QSI $2.18
  • Analyst Decision
  • IMRX Strong Buy
  • QSI Strong Buy
  • Analyst Count
  • IMRX 4
  • QSI 3
  • Target Price
  • IMRX $17.75
  • QSI $2.88
  • AVG Volume (30 Days)
  • IMRX 1.9M
  • QSI 19.1M
  • Earning Date
  • IMRX 11-12-2025
  • QSI 11-05-2025
  • Dividend Yield
  • IMRX N/A
  • QSI N/A
  • EPS Growth
  • IMRX N/A
  • QSI N/A
  • EPS
  • IMRX N/A
  • QSI N/A
  • Revenue
  • IMRX N/A
  • QSI $3,412,000.00
  • Revenue This Year
  • IMRX N/A
  • QSI N/A
  • Revenue Next Year
  • IMRX N/A
  • QSI $219.33
  • P/E Ratio
  • IMRX N/A
  • QSI N/A
  • Revenue Growth
  • IMRX N/A
  • QSI 100.47
  • 52 Week Low
  • IMRX $1.10
  • QSI $0.61
  • 52 Week High
  • IMRX $10.08
  • QSI $5.77
  • Technical
  • Relative Strength Index (RSI)
  • IMRX 51.11
  • QSI 59.50
  • Support Level
  • IMRX $5.23
  • QSI $2.22
  • Resistance Level
  • IMRX $6.44
  • QSI $2.44
  • Average True Range (ATR)
  • IMRX 0.44
  • QSI 0.28
  • MACD
  • IMRX -0.00
  • QSI -0.01
  • Stochastic Oscillator
  • IMRX 71.58
  • QSI 43.74

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

About QSI Quantum-Si Incorporated

Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.

Share on Social Networks: